196 related articles for article (PubMed ID: 33359228)
1. Comparison of Outcomes with or without Beta-Blocker Therapy After Acute Myocardial Infarction in Patients Without Heart Failure or Left Ventricular Systolic Dysfunction (from the Acute Coronary Syndromes Israeli Survey [ACSIS]).
El Nasasra A; Beigel R; Klempfner R; Alnsasra H; Matetzky S; Iakobishvili Z; Rubinshtein R; Halabi M; Blatt A; Zahger D
Am J Cardiol; 2021 Mar; 143():1-6. PubMed ID: 33359228
[TBL] [Abstract][Full Text] [Related]
2. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
[TBL] [Abstract][Full Text] [Related]
3. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
Perera D; Crake T; Lee V
Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
[TBL] [Abstract][Full Text] [Related]
5. Effects of β-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction.
Horiuchi Y; Tanimoto S; Aoki J; Nakajima H; Hara K; Tanabe K
Int J Cardiol; 2016 Oct; 221():765-9. PubMed ID: 27428318
[TBL] [Abstract][Full Text] [Related]
6. The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics.
Kristensen AMD; Munkhaugen J; Halvorsen S; Olsen MH; Bakken A; Sehested TSG; Ruddox V; Lange T; Fagerland MW; Torp-Pedersen C; Prescott E; Atar D
Eur Heart J Cardiovasc Pharmacother; 2024 May; 10(3):175-183. PubMed ID: 38017624
[TBL] [Abstract][Full Text] [Related]
7. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of beta-blockers at discharge on long-term clinical outcomes in patients with non-reduced ejection fraction after acute myocardial infarction.
Sakagami A; Soeda T; Saito Y; Nakao K; Ozaki Y; Kimura K; Ako J; Noguchi T; Suwa S; Fujimoto K; Dai K; Morita T; Shimizu W; Hirohata A; Morita Y; Inoue T; Okamura A; Mano T; Wake M; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Tobaru T; Saku K; Oshima S; Miyamoto Y; Ogawa H; Ishihara M;
J Cardiol; 2023 Jan; 81(1):83-90. PubMed ID: 35995686
[TBL] [Abstract][Full Text] [Related]
9. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
10. Secondary adherence to beta-blockers after ST-elevation myocardial infarction without ventricular dysfunction.
Padilla López A; Alós-Almiñana M; Peris JE
Med Clin (Barc); 2020 Sep; 155(6):242-248. PubMed ID: 31932044
[TBL] [Abstract][Full Text] [Related]
11. Influence of left ventricular systolic function on the long-term benefit of beta-blockers after ST-segment elevation myocardial infarction.
Velásquez-Rodríguez J; Bruña V; Vicent L; Díez-Delhoyo F; Valero-Masa MJ; Sousa-Casasnovas I; Juárez M; Devesa C; Fernández-Avilés F; Martínez-Sellés M
Rev Port Cardiol (Engl Ed); 2021 Apr; 40(4):285-290. PubMed ID: 33642167
[TBL] [Abstract][Full Text] [Related]
12. Association of beta-blocker therapy at discharge with clinical outcomes in patients without heart failure or left ventricular systolic dysfunction after acute coronary syndrome: An updated systematic review and meta-analysis.
Hu MJ; Wang XN; Tan JS; Yang YJ
Arch Cardiovasc Dis; 2022 Dec; 115(12):637-646. PubMed ID: 36376209
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
14. Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis.
Misumida N; Harjai K; Kernis S; Kanei Y
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):280-5. PubMed ID: 26424094
[TBL] [Abstract][Full Text] [Related]
15. Beta-blocker therapy reduces mortality in patients with coronary artery disease treated with percutaneous revascularization: a meta-analysis of adjusted results.
Peyracchia M; Errigo D; Raposeiras Rubin S; Conrotto F; DiNicolantonio JJ; Omedè P; Rettegno S; Iannaccone M; Moretti C; D'Amico M; Gaita F; D'Ascenzo F
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):337-343. PubMed ID: 29877974
[TBL] [Abstract][Full Text] [Related]
16. β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.
Puymirat E; Riant E; Aissaoui N; Soria A; Ducrocq G; Coste P; Cottin Y; Aupetit JF; Bonnefoy E; Blanchard D; Cattan S; Steg G; Schiele F; Ferrières J; Juillière Y; Simon T; Danchin N
BMJ; 2016 Sep; 354():i4801. PubMed ID: 27650822
[TBL] [Abstract][Full Text] [Related]
17. Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
Fukase T; Dohi T; Koike T; Yasuda H; Takeuchi M; Takahashi N; Chikata Y; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
ESC Heart Fail; 2022 Feb; 9(1):545-554. PubMed ID: 34811932
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.
Ozasa N; Kimura T; Morimoto T; Hou H; Tamura T; Shizuta S; Nakagawa Y; Furukawa Y; Hayashi Y; Nakao K; Matsuzaki M; Nobuyoshi M; Mitsudo K;
Am J Cardiol; 2010 Nov; 106(9):1225-33. PubMed ID: 21029817
[TBL] [Abstract][Full Text] [Related]
19. Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.
Kristensen AMD; Bovin A; Zwisler AD; Cerquira C; Torp-Pedersen C; Bøtker HE; Gustafsson I; Veien KT; Thomsen KK; Olsen MH; Larsen ML; Nielsen OW; Hildebrandt P; Foghmar S; Jensen SE; Lange T; Sehested T; Jernberg T; Atar D; Ibanez B; Prescott E
Trials; 2020 May; 21(1):415. PubMed ID: 32446298
[TBL] [Abstract][Full Text] [Related]
20. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2019 Jan; 280():166-173. PubMed ID: 30529829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
